🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05689567
Active, not recruiting Not applicable

Focus-out Glasses on Emmetropization in Chinese Children

NCT05689567 · tracked via the Priya Life Science China tracker
Sponsor
Children's Hospital of Fudan University
Phase
Not applicable
Started
2023-03-23
Last updated
2026-02-24

Condition(s) studied

EmmetropizationMyopiaHyperopia

Investigational drug(s) / intervention(s)

DEFOG glasses(peripheral focus-out glasses)

DEFOG glasses(peripheral focus-out glasses): Subjects in the intervention group will wear peripheral focus-out glasses ≧8 hours a day and ≧5 days a week.

Study summary

The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.

Eligibility

Sex
ALL
Min age
6 Years
Max age
8 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Age: ≥6 and ≤8 years at enrollment. 2. At least one parent' s Spherical equivalent refraction≤-3.00D. 3. Spherical equivalent refractions (SERs) under cycloplegia: +0.50 to +1.50 diopters (D) 4. Astigmatism ≤1.00 D . 5. Anisometropia ≤1.00 D. 6. Best Corrected Visual Acuity (BCVA) : 1.0 or better 7. Provision of consent written by subject's legal guardian 8. Willing and able to participate in all required activities of the study Exclusion Criteria: 1. Any of the following abnormalities on the ocular surface, such as trachoma, pemphigoid, chemical injury, heat burn, radiation injury, etc. 2. Eyelid abnormalities (e.g. entropion, ectropion, tumor, edema, blepharospasm, incomplete eyelid closure, severe trichiasis, severe ptosis) ,which affect eyelid function in either eye 3. Eye diseases such as strabismus, amblyopia, anisometropia, fundus diseases, and accommodation abnormality,etc. 4. Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, low-level red-light therapy, etc. 5. Noncompliance with measurement at enrollment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Children's Hospital of Fudan University Shanghai Shanghai Municipality

More Children's Hospital of Fudan University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05689567 on ClinicalTrials.gov ↗ ← All trials in China